Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark: a retrospective cohort study.

Chang S, Pedersen L, Skakkebæk A, Berglund A, Gravholt CH.

Open source

DOI
10.1016/j.lanepe.2025.101230
Published
2025-02-01
Container
Lancet Reg Health Eur
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2025.101230,
  title = {Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark: a retrospective cohort study.},
  author = {Chang S and  Pedersen L and  Skakkebæk A and  Berglund A and  Gravholt CH.},
  year = {2025},
  journal = {Lancet Reg Health Eur},
  doi = {10.1016/j.lanepe.2025.101230},
  url = {https://doi.org/10.1016/j.lanepe.2025.101230}
}

RIS

TY  - JOUR
TI  - Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark: a retrospective cohort study.
AU  - Chang S
AU  -  Pedersen L
AU  -  Skakkebæk A
AU  -  Berglund A
AU  -  Gravholt CH.
PY  - 2025
JO  - Lancet Reg Health Eur
DO  - 10.1016/j.lanepe.2025.101230
UR  - https://doi.org/10.1016/j.lanepe.2025.101230
ER  - 

APA

S, C., L, P., A, S., A, B., & CH., G. (2025). Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark: a retrospective cohort study.. Lancet Reg Health Eur. https://doi.org/10.1016/j.lanepe.2025.101230

Source records